Drug Shortage Report for DIPENTUM
Report ID | 193760 |
Drug Identification Number | 02063808 |
Brand name | DIPENTUM |
Common or Proper name | Dipentum |
Company Name | ATNAHS PHARMA UK LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | OLSALAZINE SODIUM |
Strength(s) | 250MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | A07EC |
ATC description | INTESTINALANTIINFLAMMATORY AGENTS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2022-08-20 |
Actual start date | 2022-08-20 |
Estimated end date | 2024-01-10 |
Actual end date | 2023-11-24 |
Shortage status | Resolved |
Updated date | 2023-11-25 |
Company comments | N/A |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | SOVEREIGN HOUSE, MILES GRAY ROAD BASILDON, ESSEX GREAT BRITAIN SS14 3FR |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2023-11-25 | English | Compare |
v5 | 2023-11-24 | French | Compare |
v4 | 2023-11-24 | English | Compare |
v3 | 2023-06-05 | French | Compare |
v2 | 2023-06-05 | English | Compare |
v1 | 2023-06-05 | English | Compare |
Showing 1 to 6 of 6